Novo Nordisk A S (NVO) Research & Development (2012 - 2016)
Novo Nordisk A S (NVO) posted Research & Development of $651 million for the quarter ended Dec 31, 2016.
Novo Nordisk A S (NVO) Research & Development (2012 - 2016) Analysis & Trends
For the trailing twelve months through Dec 31, 2016, Research & Development at Novo Nordisk A S was $33.85 billion; for the year ended Dec 31, 2013, it was $11.73 billion, up 7.7% from the prior year.
- Annual Research & Development has increased for four consecutive years, with a four-year compound annual growth rate of 10.5% (years ended Dec 2009 to Dec 2013).
- In prior years, Novo Nordisk A S's Research & Development was $10.9 billion in the year ended Dec 31, 2012 (+13.2%), $9.63 billion in the year ended Dec 31, 2011 (+0.3%), $9.6 billion in the year ended Dec 31, 2010 (+22.1%) and $7.86 billion in the year ended Dec 31, 2009.
- The figure for the quarter ended Dec 31, 2016 stands as the highest quarterly Research & Development since the quarter ended Dec 31, 2014.
Peer Comparison
Historic Data
| Date | Value |
|---|---|
| Dec 31, 2016 | 651.00 Mn |
| Dec 31, 2014 | 13.76 Bn |
| Dec 31, 2012 | 10.90 Bn |
Novo Nordisk A S Research & Development API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=research-and-development&ticker=NVO&period=max&api_key=YOUR_API_KEY
import requests
url = "https://data.businessquant.com/historic"
params = {"slug": "research-and-development", "ticker": "NVO", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()
const res = await fetch("https://data.businessquant.com/historic?slug=research-and-development&ticker=NVO&period=max&api_key=YOUR_API_KEY");
const data = await res.json();